20 pack-years better indicator of high-risk disease
Opportunity for more nuanced approach
Lenvatinib promising, trials ongoing
Postsurgery chemo for certain head and neck cancers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Extends the benefits of NSM to more patients and improves outcomes
Skilled team provides advanced surgical interventions
A recent clinical trial tested neoadjuvant therapies
Choroid lesions indicate systemic disease
Safe, effective, welcome option
Precision therapy for refractory disease now FDA approved
Advertisement
Advertisement